Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Thio Oligonucleotide. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1409719A details a stepwise sulfur transfer process for high-purity oligonucleotides, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel C-P bond modification strategy enhances siRNA stability and Ago2 affinity. Reliable supplier for complex oligonucleotide intermediates with scalable solid-phase synthesis.
Patent CN116444589B reveals liquid phase coupling boosting yield over 10 times solid phase methods for high-purity pharmaceutical intermediates.
Patent CN116444589B reveals high-yield liquid phase synthesis for GalNAc conjugates. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates significantly.